InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by ENGLE J MELVILLE, Chief Executive Officer. Insider active across 1 company, notably Predictive Oncology Inc.. In total, 8 filings have been recorded. Split: 1 buy · 0 sell. Total volume traded: €55k. Activity tracked since 1 July 2021. The latest transaction was disclosed on 1 November 2022 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations8 total
213,300 shares0Common StockSEC:0001415889-22-010959:0
159,500 shares@ US$0.372100.0% of flowCommon StockSEC:0001415889-22-005573:0
Ideal exit: 18 Feb 2023 (T+270)
20,428 shares0Common StockSEC:0001179110-22-000327:0
20,428 shares0Common StockSEC:0001179110-22-000327
4,512 shares0Common StockSEC:0001179110-21-009200:0
4,512 shares0Common StockSEC:0001179110-21-009200
9,924 shares0Common StockSEC:0001179110-21-007393
9,924 shares0Common StockSEC:0001179110-21-007393:0
8 of 8 declarations
About ENGLE J MELVILLE
J. Melville Engle is the CEO and Chairman at Predictive Oncology Inc. He is responsible for the strategic and operational direction of the company. His role includes managing resources and making key decisions to ensure growth and profitability. Through his leadership, he guides the company towards achieving its long-term objectives.
